PATRICK GREGORY S (VP, Chief Financial Officer) sold 29.5% of their position (20K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $830.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/28/2019ACC: 0001104659-19-011559
Officer· VP, Chief Financial Officer
Since Jul 2018
-20K
Net shares
Net seller
$830.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20K acquired · 40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20K
Price / share
$9.13
Trade value
$182.60K
% of position
41.8%
2/27/2019
47.90K→67.90K
Common Stock
Direct
Shares
−20K
Price / share
$41.53
Trade value
$830.65K
% of position
29.5%
2/27/2019
67.90K→47.90K
Total
Net shares
+0.00
Net value
-$648.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2019 | M · Option Exercise | +20K | $9.13 | $182.60K | 41.8% | 47.90K | 67.90K |
| Common Stock Direct | 2/27/2019 | S · Sale | −20K | $41.53 | $830.65K | 29.5% | 67.90K | 47.90K |
| Total | +0.00 | -$648.05K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
20K shares
Shares
−20K
Strike price
9.13
Held after
15K
Exercisable
—
2/27/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock20K shares | 2/27/2019 | M · Option Exercise | −20K | 9.13 | — | 15K |